Higher prevalence of depressive and anxiety symptoms in early arthritis patients in comparison to the normal population

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00011303

Enrollment

180

Registered

2017-02-03

Start date

2011-01-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M13.0 F43

Interventions

Group 1: Early rheumatoid patients with an inflammatory joint symptom between 4 weeks and 12 months are continuously compared in the HADS Group 2: Published reference data on HADS from the normal popu

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: age = 18 years; at least one swollen joint; symptoms duration between 4 weeks and 12 months; fully documented HADS questionnaire

Exclusion criteria

Exclusion criteria: criteria for early arthritis are not applicable; suspected of trauma, surgery, infections in the area of symptomatic joints

Design outcomes

Primary

Measure	Time frame
Prevalence rates of depression and anxiety in early arthritis patients at first visiting by the rheumatologist measured by the Hospital Anxiety and Depression Scale (HADS)	—

Secondary

Measure	Time frame
Comparison of factors influencing both rheumatic disease and depression and anxiety disorders (e.g., indicators of disease activity, age, gender)	—

Countries

Germany

Contacts

Public ContactDesiree Freier

Charité-Universitätsmedizin Berlin Klinik m.S. Rheumatologie und Klinische Immunologie

desiree.freier@charite.de+49-30450513-133

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026